Trial Profile
Efficacy and Safety of Gefitinib in combination with chemotherapy in recurrent or metastatic head and neck cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Sep 2015
Price :
$35
*
At a glance
- Drugs Gefitinib (Primary) ; Carboplatin; Cisplatin; Paclitaxel
- Indications Head and neck cancer
- Focus Therapeutic Use
- 28 Sep 2015 New trial record